Stock Events

Stock Events

Cadrenal Therapeutics (CVKD) Q3 2024 Earnings

7AugConfirmed

Q4 2022

Q4 2023

Q2 2024

Q3 2024

-2.25

-1.5

-0.75

0

Details

Expected EPS

-1.275

Actual EPS

-2.25

Surprise EPS

-0.98

Surprise Percent

+76.47%

Description

Cadrenal Therapeutics (CVKD) has reported earnings of -2.25 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.